| Nov 14 |
European committee takes a second look at Alzheimer's drug and now says it should be approved
|
| Nov 14 |
5 Healthcare Stocks to Buy in a Beaten-Up Sector
|
| Nov 14 |
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
|
| Nov 14 |
Biogen gains as Eisai wins EU nod for Alzheimer’s drug
|
| Nov 14 |
Syros Stock Plunges as Lead Cancer Study Fails to Meet Primary Goal
|
| Nov 14 |
Peeling Back The Layers: Exploring Biogen Through Analyst Insights
|
| Nov 14 |
Citi initiates coverage on 5 new biotech stocks
|
| Nov 14 |
RNA Stock Hits Record High on Entering the Cardiac Disease Space
|
| Nov 13 |
Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut
|
| Nov 12 |
Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View
|
